Article
Pregnancy and COVID ‐19: pharmacologic considerations
22 Sept 2020
Abstract excerpt
In this review, we summarize evidence regarding the use of routine and investigational pharmacologic interventions for pregnant and lactating patients with coronavirus disease 2019 (COVID-19). Antenatal corticosteroids may be used routinely for fetal lung maturation between 24 and 34 weeks' gestation, but decisions in those with critical illness and those < 24 or > 34 weeks' gestation should be made on a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
